Health care utilization and steroid‐refractory toxicities from immune checkpoint inhibitors
Sign Up to like & getrecommendations! Published in 2019 at "Cancer"
DOI: 10.1002/cncr.32542
Abstract: Anti–programmed death protein 1 (anti–PD‐1) agents have transformed the treatment of advanced melanoma and other cancers, but the rates of steroid‐refractory toxicities and health care utilization are not well described. This study assessed these endpoints… read more here.
Keywords: care utilization; refractory toxicities; health care; steroid refractory ... See more keywords